Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Euronext Alternext  >  Median Techno    ALMDT   FR0011049824

MEDIAN TECHNO (ALMDT)

10
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensus 
News SummaryMost relevantAll newsSector news 

MEDIANTECHNOLOGIES : MEDIAN Technologies Names Ciaran Cooper as Head of Business Development, Clinical Trials Imaging, North America

04/04/2012 | 01:35am US/Eastern

Ciaran Cooper will be responsible for developing the company's US market in oncology clinical trials and will assist in managing the relationship between MEDIAN and Quintiles

MEDIAN Technologies (Paris:ALMDT), a leading medical imaging software solutions developer, and a service provider for image interpretation and management in oncology clinical trials, announced today that it has named Ciaran Cooper as Head of Business Development, Clinical Trials Imaging, North America. Ciaran Cooper will be responsible for developing the company's US market in oncology clinical trials and will assist in managing the strategic relationship between MEDIAN Technologies and Quintiles.

Ciaran Cooper, an entrepreneur and early innovator in the clinical trials imaging services industry, brings over 20 years' experience in medical imaging with an emphasis in business development, strategic planning, and team management. Along with colleagues from the University of Chicago, Ciaran Cooper co-founded MIICRO, Inc. in 1995, the first imaging CRO specialized in early phase translational imaging with FDG PET. He was CEO of MIICRO until 2003. Since then, Ciaran Cooper has worked for several imaging services and technology companies as a senior manager in business development and thus brings with him a vast knowledge of various business models, therapeutic areas, and growth strategies.

"I'm very excited to join MEDIAN at this time in their development," said Ciaran Cooper. "MEDIAN's LMS solution provides a quantum leap forward in how medical imaging can be applied to oncology clinical trials. I look forward to carrying our message to market."

"We're thrilled to welcome Ciaran to our team," said Jerome Windsor, VP Business Development at MEDIAN Technologies. "Ciaran has a unique perspective on the industry and he brings an entrepreneurial spirit and enthusiasm that will fit well with our growing company."

About MEDIAN Technologies: For more information on MEDIAN, please visit: www.mediantechnologies.com

MEDIAN Technologies
Fredrik Brag, CEO
+33 4 92 90 65 82
fredrik.brag@mediantechnologies.com
or
Press - ALIZE RP
Caroline Carmagnol
+ 33 6 64 18 99 59 // + 33 1 42 68 86 43
caroline@alizerp.com
Anne-Sophie Cosquéric
+ 33 1 42 68 86 41
Anne-sophie@alizerp.com


© Business Wire 2012
React to this article
Latest news on MEDIAN TECHNO
07/03 MEDIAN TECHNO : ogies : Announces a Private Placement of €19.8 Million at a €12 ..
06/27 MEDIAN TECHNO : ogies Updates on New Awarded Projects
06/26 MEDIAN TECHNO : ogies Updates on New Awarded Projects and Contract
06/23 MEDIAN TECHNO : ogies Updates on New Awarded Projects and Contract
06/23 MEDIAN TECHNO : ogies Updates on New Awarded Projects
06/18 MEDIAN TECHNO : ogies : Announces New Awarded Projects and a New Contract for Im..
06/18 MEDIAN TECHNO : ogies Announces New Awarded Projects and a New Contract for Imag..
05/28 MEDIAN TECHNO : ogies : at the 2015 ASCO Annual Meeting
04/18 MEDIAN TECHNO : Reports New Medical Image Interpretation and Management Projects..
04/15 MEDIAN TECHNO : ogies: 2014 Results
Advertisement
Chart
Duration : Period :
Median Techno Technical Analysis Chart | ALMDT | FR0011049824 | 4-Traders